© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Posted 18th February 2020

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Title21

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. From reporting to analytics, Title21 provides all the critical data at your fingertips so the right person has the right data at the right time to make the right decisions. This allows Medical Technologists, Technical and Medical Directors to focus on higher-value work, and ultimately the patient, rather than chasing down paperwork and people.

Earlier this year, Title21 was selected as the Most Outstanding Cell Therapy Software Provider for 2019 by AI’s Global Excellence Award. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Since their inception, Tile21’s Cloud and onpremise software manages critical patient, product and process data for cell and gene therapy, immunotherapy and regenerative medicine to ensure quality, compliance and traceability. Programs that implement Title21 solutions find they can scale more effectively to treat more patients and can also translate products more quickly and efficiently from bench to bedside, delivering the latest innovative therapies to patients faster and more safely.

Title21 has served FDA-regulated life science companies for many years with quality management software, so Title21’s experience has been of great service to the cell therapy segment. “Our technology is extremely flexible due to its configurability on the front end. That means that we can maintain a single code base while meeting each cancer center or cell manufacturers’ specific requirements.”

“Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day.”

“At Title21, we partner with the largest and top-rated cancer hospitals – placing the patient first. One of our greatest testimonials we hear often is that our customers want us to continue to solve more of their challenges with our technology. They ask Title21 to help provide solutions through technology to increase the quality, safety and efficiency of their programs.” Current Title21 customers have a strong influence on the technology roadmap to add value to patient therapeutic care and quality. Analytics and business intelligence are also important and play a significant role in the future of developing new cures and protocols more quickly and efficiently. Cell and gene therapy is a dynamic market and the protocols are changing rapidly as they are improved and refined.

Moving forward, the future looks bright for the team at Title21 as they continue to provide exceptional services and award-winning solutions to hospitals and biotech firms. “Our passion is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments to their patients. Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day” remarks Fischer.

Bringing the interview to a close, Lynn signs off by revealing the exciting plans which lie in the pipeline for the business, which includes their ambitions to further expand the business in the years to come, especially with the advancements in immunotherapy technology.

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
5 Ways AI Is Outperforming Experts
Innovation
07/03/20225 Ways AI Is Outperforming Experts

With DeepMind claiming that its AI system – AlphaCode – can “write computer code at a competitive level,” a milestone may have been reached. The ability of a machine to match the coding skills typical of human intelligence, if true, represents a moment

Read Full PostRead - Eye Icon
Car Accident Lawyers in Brooklyn, NY: Top 8 Picks Updated for 2027
Legal
13/11/2026Car Accident Lawyers in Brooklyn, NY: Top 8 Picks Updated for 2027

For anyone who works in Brooklyn, a crash can cost more than a car. Time off for treatment, lost income and questions about whether the accident counts as work-related all land at once, often while insurers are already calling. This list profiles eight Brookly

Read Full PostRead - Eye Icon
Inventory & Natural Disasters: How Businesses Can Prepare
Strategy
28/04/2021Inventory & Natural Disasters: How Businesses Can Prepare

Businesses that effectively position their inventory are better equipped to respond to natural disasters. They are also able to assist communities in need.

Read Full PostRead - Eye Icon
A Smooth Transition
Finance
26/07/2022A Smooth Transition

FP Transitions is a specialized business consulting firm dedicated to wealth managers and independent financial advisors with over twenty years of industry expertise.

Read Full PostRead - Eye Icon
Structuring Success:  Corporate Governance Within Papua New Guinea
Finance
08/04/2015Structuring Success: Corporate Governance Within Papua New Guinea

Corporate Governance in Papua New Guinea leaves much to be desired, particularly in the government sector and the many ‘State Owned Enterprises’.

Read Full PostRead - Eye Icon
7 Essential Strategies for Enhancing Global Business Communication in 2024
News
25/04/20247 Essential Strategies for Enhancing Global Business Communication in 2024

You’re navigating the global business arena, looking to sharpen communication strategies for your international operations. It’s clear that fostering effective dialogue across borders can make or break success in today’s interconnected market

Read Full PostRead - Eye Icon
6 Examples of How Advanced Automation is Making Businesses More Efficient Than Ever
News
16/10/20236 Examples of How Advanced Automation is Making Businesses More Efficient Than Ever

In a fast-paced business environment where efficiency is king, advanced automation has emerged as the game-changing factor.  From mammoth manufacturing powerhouses to small-scale retail operations, every sector is witnessing an efficiency revolution drive

Read Full PostRead - Eye Icon
Corinthia Hotels Announces the Acquisition of the Grand Hotel Astoria, Brussels
Finance
17/05/2016Corinthia Hotels Announces the Acquisition of the Grand Hotel Astoria, Brussels

Corinthia Hotels Announces the Acquisition of the Hotel Astoria in Brussels.

Read Full PostRead - Eye Icon
How APIs & SDKs Are Transforming The Enterprise IT Landscape
News
07/09/2023How APIs & SDKs Are Transforming The Enterprise IT Landscape

The endless acronyms used in enterprise IT can get overwhelming, but it’s worth knowing about a few lynchpin examples, whether or not your role is technical. Let’s focus on APIs and SDKs, two niches that continue to create evolving opportunities fo



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow